Preprint · 2026 · Open access

Targeting autoimmunity in Rheumatoid Arthritis with nanoparticles displaying Liprin-1 peptide

Anthony Rosa, Alessia Raneri, Michela Campolo, Emanuela Esposito, Elisa Gecchele, John E. Butler, Julian Ma, Nidhi Sofat, Santiago Figueira, Denise Pivotto, Alison Ms Cormick, Elena Bartoloni and 2 more

bioRxiv (Cold Spring Harbor Laboratory) · Published 10 January 2026 · DOI 10.64898/2026.01.09.698578

Open full textCite this paper

In brief

“Targeting autoimmunity in Rheumatoid Arthritis with nanoparticles displaying Liprin-1 peptide” is a 2026 preprint by Anthony Rosa and 13 co-authors, published in bioRxiv (Cold Spring Harbor Laboratory). OpenAlex counts 1 citations as of 18 November 2026. It is open access: the full text is free to read at bioRxiv (Cold Spring Harbor Laboratory).

Citations
1
Most cited in
2026 (1)
References
57
Authors
14

Abstract

Nanoparticle-based strategies offer a promising tool for inducing antigen-specific immune tolerance across various autoimmune conditions, by acting as master switch to turn-off the autoimmune response. Building on our previous work demonstrating the therapeutic potential of plant-made nanoparticles in rheumatoid arthritis, we present a systematic evaluation of key parameters—including dosing regimen, route of administration, and immunization schedule—to optimize both efficacy and safety. We developed virus-based nanomaterials expressing Tomato Bushy Stunt Virus (TBSV) nanoparticles engineered to display the immunodominant Liprin-1 peptide in the Nicotiana benthamiana plant platform. The mechanisms responsible for the observed protective effects against rheumatoid arthritis were also investigated. Our findings highlight the critical role of repeated intravenous administration and precise dosing in promoting regulatory T cell (Treg) induction and cytokine modulation. Furthermore, we dissected the individual contributions of the Liprin-1 peptide and the viral capsid scaffold in driving immune tolerance. These results support the potential of plant-derived nanoparticles as a versatile and effective platform for antigen-specific immunotherapy, with rheumatoid arthritis serving as a proof-of-concept model for broader applications in the field of autoimmunity. One Sentence Summary Plant-made nanomaterials induce tolerance in arthritis models via repeated IV dosing, triggering an antigen-specific regulatory immune response.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Rosa, A., Raneri, A., Campolo, M., Esposito, E., Gecchele, E., Butler, J. E., Ma, J., Sofat, N., Figueira, S., Pivotto, D., Cormick, A. M., Bartoloni, E., Zampieri, R., & Avesani, L. (2026). Targeting autoimmunity in Rheumatoid Arthritis with nanoparticles displaying Liprin-1 peptide. bioRxiv (Cold Spring Harbor Laboratory). https://doi.org/10.64898/2026.01.09.698578

MLA 9

Rosa, Anthony, et al. “Targeting autoimmunity in Rheumatoid Arthritis with nanoparticles displaying Liprin-1 peptide.” bioRxiv (Cold Spring Harbor Laboratory), 2026. https://doi.org/10.64898/2026.01.09.698578.

Chicago

Rosa, Anthony, Alessia Raneri, Michela Campolo, Emanuela Esposito, Elisa Gecchele, John E. Butler, Julian Ma, et al. 2026. “Targeting autoimmunity in Rheumatoid Arthritis with nanoparticles displaying Liprin-1 peptide.” bioRxiv (Cold Spring Harbor Laboratory). https://doi.org/10.64898/2026.01.09.698578.

Harvard

Rosa, A. et al. (2026) ‘Targeting autoimmunity in Rheumatoid Arthritis with nanoparticles displaying Liprin-1 peptide’, bioRxiv (Cold Spring Harbor Laboratory). doi:10.64898/2026.01.09.698578.

IEEE

A. Rosa et al., “Targeting autoimmunity in Rheumatoid Arthritis with nanoparticles displaying Liprin-1 peptide,” bioRxiv (Cold Spring Harbor Laboratory), 2026, doi: 10.64898/2026.01.09.698578.

BibTeX

@misc{rosa2026targeting,
  title     = {{Targeting autoimmunity in Rheumatoid Arthritis with nanoparticles displaying Liprin-1 peptide}},
  author    = {Rosa, Anthony and Raneri, Alessia and Campolo, Michela and Esposito, Emanuela and Gecchele, Elisa and Butler, John E. and Ma, Julian and Sofat, Nidhi and Figueira, Santiago and Pivotto, Denise and Cormick, Alison Ms and Bartoloni, Elena and Zampieri, Roberta and Avesani, Linda},
  howpublished = {bioRxiv (Cold Spring Harbor Laboratory)},
  year      = {2026},
  doi       = {10.64898/2026.01.09.698578},
  url       = {https://doi.org/10.64898/2026.01.09.698578}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Transgenic Plants and Applications

  • rheumatoid arthritis
  • autoimmunity
  • antigen-specific tolerance
  • tomato bushy stunt virus
  • Nicotiana benthamiana
  • regulatory T cell induction
  • intravenous administration
  • cytokine modulation

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Rosa, A., Raneri, A., Campolo, M., Esposito, E., Gecchele, E., Butler, J. E., Ma, J., Sofat, N., Figueira, S., Pivotto, D., Cormick, A. M., Bartoloni, E., Zampieri, R., & Avesani, L. (2026). Targeting autoimmunity in Rheumatoid Arthritis with nanoparticles displaying Liprin-1 peptide. bioRxiv (Cold Spring Harbor Laboratory). https://doi.org/10.64898/2026.01.09.698578

How many times has this paper been cited?

1 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at bioRxiv (Cold Spring Harbor Laboratory): sign in and open the full text from this page.

Who wrote this paper?

Anthony Rosa, Alessia Raneri, Michela Campolo, Emanuela Esposito, Elisa Gecchele, John E. Butler, Julian Ma, Nidhi Sofat, Santiago Figueira, Denise Pivotto, Alison Ms Cormick, Elena Bartoloni and 2 more.

What is the DOI of this paper?

10.64898/2026.01.09.698578, permanently at https://doi.org/10.64898/2026.01.09.698578. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.